The carboxy therapy market size is projected to reach US$ 0.28 billion by 2031 from US$ 0.11 billion in 2023. The market is expected to register a CAGR of 17.6% during 2023–2031. An increase in application areas will likely remain a key trend in the market.
The market drivers include the growing adoption of non-invasive aesthetic procedures, increasing demand for antiaging treatments, and the surge in the geriatric population. Furthermore, the untapped potential of emerging economies is a crucial opportunity for the carboxy therapy market players.
The World Health Organization (WHO) recognizes waste reduction in healthcare delivery as an essential aspect of strengthening healthcare systems. Technological advancements have led to the development of surgical approaches that minimize waste and achieve better results with available resources. Minimally invasive surgeries (MIS) and non-invasive procedures are among the approaches that result in low waste generation and reduced medical expenses. Moreover, these procedures ensure low absenteeism at the workplace, which has a net positive effect on the productivity of an economy. According to the International Society of Aesthetic Plastic Surgery, 14,400,347 million minimally invasive cosmetic procedures were performed globally in 2020. The use of these procedures rose by 22.7% during 2016-2020 on a global level, and they now account for ~59% of aesthetic interventions in the country.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Carboxy therapy Market: Strategic Insights
The elderly population in the world is anticipated to reach 1.4 billion in 2030, 2.1 billion in 2050, and more than 3.1 billion in 2100. The Global Ageing 2019 survey deduced that the world's population of people aged 65 and above totaled 703 million in 2019. The elderly population is expected to double to 1.5 billion by 2050. The frequency of people aged 65 or above is likely to increase from 1 in 11 to 1 in 6 from 2019 to 2025. According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. The number of Americans aged 65 and above is estimated to increase from 46 million in 2016 to more than 98 million by 2060, and this demographic group will account for ~24% of the global population by 2060, up from 15% in 2016, states the US Census Bureau.
Carboxy therapy involves the use of carbon dioxide gas as injectables, and increasing application areas made it one of the most used treatment modalities in dermatology, aesthetic medicine, and anti-aging medicine. As the therapy started gaining traction in the past few years, significant developments have occurred in the devices used for the treatments. Conventional devices are in the form of pens, which are small in size but heavy in nature, which makes them difficult to hold during long sessions. This led to the development of devices that are sophisticated and easy to use. Additionally, increased innovations and technological advancements allow multiple puncture techniques for a distance of 1 cm for boluses.
Key segments that contributed to the derivation of the carboxy therapy market analysis are offerings, usage, and end users.
The geographic scope of the carboxy therapy market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
In North America, the US carboxy therapy market holds the largest share of the region. The growth of the market in the country is defined by various factors, such as the rise in the development of non-invasive and minimally invasive procedures, which has exponentially increased the aesthetics procedures such as fat reduction and antiaging treatments. A study by the American Society of Plastic Surgeons 2020 states that 15.6 million cosmetic treatments were done in 2020, with 13.2 million cosmetic minimally invasive procedures and about 2.3 million cosmetic surgical operations. Additionally, the increasing application areas of carboxytherapy in medical fields such as neurology, gynecology, and urology are also expected to contribute significantly to the growth of the carboxy therapy market.
The regional trends and factors influencing the Carboxy therapy Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Carboxy therapy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 0.11 Billion |
| Market Size by 2031 | US$ 0.28 Billion |
| Global CAGR (2023 - 2031) | 17.6% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Carboxy therapy Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Carboxy therapy Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Carboxy therapy Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the carboxy therapy market are listed below:
The “Carboxy therapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
North America dominated the carboxy therapy market in 2023
The market drivers include the growing adoption of non-invasive aesthetic procedures, increasing demand for antiaging treatments, and the surge in the geriatric population. However, regulatory policies and safety concerns associated with carbon therapy are key restraining factors for the market growth.
An increase in application areas will likely remain a key trend in the market.
DTA Medical; Cosmo Pro Ltd; Beijing Jontelaser Technologies Co., Ltd.; Kastner-Praxisbedarf; Mezopharma; Carbossiterapia Italiana, MBE Medical Division; Nick Fanavaran Plasma Company.
The market is expected to register a CAGR of 17.6% during 2023–2031.